1-(Cyclopropylcarbonyl)piperazine Hydrochloride CAS 1021298-67-8 Purity ≥99.0% Olaparib Intermediate Hoobkas Featured duab

1-(Cyclopropylcarbonyl)piperazine Hydrochloride CAS 1021298-67-8 Purity ≥99.0% Olaparib Intermediate Factory

Lus piav qhia luv luv:

Lub npe: 1-(Cyclopropylcarbonyl)piperazine Hydrochloride

CAS: 1021298-67-8 Nr

Purity: ≥99.0%

Cov tsos mob: Dawb hmoov

Intermediate of Olaparib (CAS: 763113-22-0) PARP-Inhibitor

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Xa email rau peb

Product Detail

Yam khoom

Khoom cim npe

Nqe lus piav qhia:

Olaparib thiab Related Intermediates:
Olaparib CAS 763113-22-0
2-Fluoro-5-Formylbenzonitrile CAS 218301-22-5
2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid CAS 763114-26-7
1- (Cyclopropylcarbonyl) Piperazine Hydrochloride CAS 1021298-67-8
Tom ntej: 3-Oxo-1,3-Dihydroisobenzofuran-1-Ylphosphonic Acid CAS 61260-15-9

Chemical Properties:

Tshuaj npe	1- (Cyclopropylcarbonyl)piperazine Hydrochloride
CAS Nr	1021298-67-8
CAT Number	Qauv TSIS MUAJ: RF-PI452
Tshuag xwm txheej	Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons
Molecular Formula	C8H14N2O · HCl
Molecular Luj	190.67 Nws
Melting Point	175.0 txog 179.0 ℃
Solubility	Soluble hauv dej
Hom	Ruifu Tshuaj

Specifications:

Yam khoom	Specifications
Qhov tshwm sim	Dawb hmoov
Purity	≥99.0%
Moisture (KF)	≤0.50%
Ib leeg Impurity	≤0.50%
Tag nrho cov impurities	≤ 1.0%
Test Standard	Enterprise Standard
Kev siv	Pharmaceutical Intermediate

Pob & Cia:

Pob: Lub raj mis, Aluminium ntawv ci hnab, Cardboard Nruas, 25kg / Nruas, los yog raws li tus neeg yuav tsum tau muaj.

Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo.

Qhov zoo:

FAQ:

Daim ntawv thov:

1-(Cyclopropylcarbonyl)piperazine Hydrochloride (CAS: 1021298-67-8) yog siv los ua tshuaj nruab nrab.Nws tuaj yeem siv los ua tus nruab nrab ntawm Olaparib (CAS: 763113-22-0).Olaparib yog ib qho muaj zog inhibitor ntawm ob qho tib si PARP-1 thiab PARP-2 thiab muaj kev nkag siab zoo rau KB2P hlwb vim muaj kev cuam tshuam ntawm kev kho lub hauv paus los ntawm PARP inhibition.Olaparib tau pom zoo hauv xyoo 2014 los ntawm FDA rau kev kho mob qog noj ntshav ntawm zes qe menyuam.